Intelligent Bio Solutions Income from Discontinued Operations 2020-2025 | INBS

Intelligent Bio Solutions income from discontinued operations from 2020 to 2025. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.

Intelligent Bio Solutions Income from Discontinued Operations 2020-2025 | INBS

Intelligent Bio Solutions income from discontinued operations from 2020 to 2025. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$151.7B
CVS Health (CVS)$90.4B
Elevance Health (ELV)$71.3B
Cencora (COR)$56.7B
DiDi Global (DIDIY)$27.6B
Labcorp Holdings (LH)$23.1B
Natera (NTRA)$22.7B
BioMerieux (BMXMF)$17.5B
EUROFINS SCIENT (ERFSF)$15.7B
ICON (ICLR)$14.2B
Medpace Holdings (MEDP)$13B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$12.8B
Viatris (VTRS)$12.4B
Caris Life Sciences,�Inc (CAI)$11.1B
Revvity (RVTY)$10.9B
Avantor (AVTR)$9B
Sonic Healthcare (SKHHY)$8B
Charles River Laboratories (CRL)$8B
HealthEquity (HQY)$7.8B
Bausch + Lomb (BLCO)$5.3B
Sotera Health (SHC)$4.7B
BrightSpring Health Services (BTSG)$4.4B
Amplifon S.p.A (AMFPF)$3.9B
KindlyMD (NAKA)$3.8B
GeneDx Holdings (WGS)$3.7B
Alignment Healthcare (ALHC)$3.1B
Concentras Parent (CON)$3B
Surgery Partners (SGRY)$3B
Organon (OGN)$2.5B